22098-10-8

Usage

Uses

Used in Chemical Synthesis:
ETHYL (5-BROMOTHIEN-2-YL)GLYOXYLATE is used as a chemical intermediate for the synthesis of various organic compounds due to its complex structural composition and potential reactivity in chemical transformations.
Used in Pharmaceutical Industry:
ETHYL (5-BROMOTHIEN-2-YL)GLYOXYLATE is used as a building block in the development of new pharmaceuticals, leveraging its unique structural features to create novel drug candidates.
Used in Material Science:
ETHYL (5-BROMOTHIEN-2-YL)GLYOXYLATE is used as a component in the synthesis of advanced materials, such as polymers and composites, where its structural elements can contribute to desired material properties.
Used in Research and Development:
ETHYL (5-BROMOTHIEN-2-YL)GLYOXYLATE is used as a research compound in academic and industrial laboratories to explore its chemical properties and potential applications in various fields.

InChI:InChI=1/C8H7BrO3S/c1-2-12-8(11)7(10)5-3-4-6(9)13-5/h3-4H,2H2,1H3

Upstream product

• 1003-09-4 2-bromothiophene 
• 4755-77-5 Ethyl oxalyl chloride 

Downstream Products

• 143365-53-1 ethyl α-phenyl-α-<2-(5-bromothienyl)>-α-hydroxyacetate 

Relevant academic research and scientific papers

Three-Component Activation/Alkynylation/Cyclocondensation (AACC) Synthesis of Enhanced Emission Solvatochromic 3-Ethynylquinoxalines

2-Substituted 3-ethynylquinoxaline chromophores can be readily synthesized by a consecutive activation–alkynylation–cyclocondensation (AACC) one-pot sequence in a three-component manner. In comparison with the previously published four-component glyoxylation starting from electron-rich π-nucleophiles, the direct activation of (hetero)aryl glyoxylic acids allows the introduction of substituents that cannot be directly accessed by glyoxylation. By introducing N,N-dimethylaniline as a strong donor in the 2-position, the emission solvatochromicity of 3-ethynylquinoxalines can be considerably enhanced to cover the spectral range from blue–green to deep red–orange with a single chromophore in a relatively narrow polarity window. The diversity-oriented nature of the synthetic multicomponent reaction concept enables comprehensive investigations of structure–property relationships by Hammett correlations and Lippert–Mataga analysis, as well as the elucidation of the electronic structure of the emission solvatochromic π-conjugated donor–acceptor systems by DFT and time-dependent DFT calculations with the PBEh1PBE functional for a better reproduction of the dominant charge-transfer character of the longest wavelength absorption band.

PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS

The present invention relates to compounds II useful as inhibitors of treating tuberculosis. The invention also provides processes for preparing compounds of the invention.

SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS

According to the present invention there is provided a compounds of formula (I): and pharmaceutically acceptable salts thereof.

Synthesis and receptor affinities of new 3-quinuclidinyl α-heteroaryl-α- aryl-α-hydroxyacetates

Five analogues of 3-quinuclidinyl benzilate were prepared in which one phenyl ring was substituted by a heterocycle; a bromine was included on either the remaining phenyl or the heterocycle to provide information relating to the affinity of potential radiohalogenated derivatives. Their affinities for the muscarinic cholinergic receptor were determined. Replacing a phenyl ring with either the 2- or 3-furyl moiety or the 2- or 3-thienyl moiety did not significantly alter the affinity to the muscarinic receptor compared with 3-quinuclidinyl 4-bromobenzilate.